RS63622B1 - Peptidomimetik beta-ukosnice sa aktivnošću inhibitora elastaze i njegovi dozni oblici aerosola - Google Patents

Peptidomimetik beta-ukosnice sa aktivnošću inhibitora elastaze i njegovi dozni oblici aerosola

Info

Publication number
RS63622B1
RS63622B1 RS20220923A RSP20220923A RS63622B1 RS 63622 B1 RS63622 B1 RS 63622B1 RS 20220923 A RS20220923 A RS 20220923A RS P20220923 A RSP20220923 A RS P20220923A RS 63622 B1 RS63622 B1 RS 63622B1
Authority
RS
Serbia
Prior art keywords
beta
dosage forms
inhibitory activity
aerosol dosage
elastase inhibitory
Prior art date
Application number
RS20220923A
Other languages
English (en)
Inventor
Piet Bruijnzeel
Johann Zimmermann
Philip Barth
Eric Chevalier
Christian Ludin
Manfred Keller
Original Assignee
Spexis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spexis Ag filed Critical Spexis Ag
Publication of RS63622B1 publication Critical patent/RS63622B1/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
RS20220923A 2016-05-31 2017-05-31 Peptidomimetik beta-ukosnice sa aktivnošću inhibitora elastaze i njegovi dozni oblici aerosola RS63622B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16020210 2016-05-31
EP17733738.3A EP3463281B1 (en) 2016-05-31 2017-05-31 Beta-hairpin peptidomimetic with elastase inhibitory activity and aerosol dosage forms thereof
PCT/EP2017/025157 WO2017207118A1 (en) 2016-05-31 2017-05-31 Beta-hairpin peptidomimetic with elastase inhibitory activity and aerosol dosage forms thereof

Publications (1)

Publication Number Publication Date
RS63622B1 true RS63622B1 (sr) 2022-10-31

Family

ID=56108445

Family Applications (2)

Application Number Title Priority Date Filing Date
RS20220922A RS63639B1 (sr) 2016-05-31 2017-05-31 Peptidomimetik beta-ukosnice sa aktivnošću inhibitora elastaze i njegovi dozni oblici aerosola
RS20220923A RS63622B1 (sr) 2016-05-31 2017-05-31 Peptidomimetik beta-ukosnice sa aktivnošću inhibitora elastaze i njegovi dozni oblici aerosola

Family Applications Before (1)

Application Number Title Priority Date Filing Date
RS20220922A RS63639B1 (sr) 2016-05-31 2017-05-31 Peptidomimetik beta-ukosnice sa aktivnošću inhibitora elastaze i njegovi dozni oblici aerosola

Country Status (26)

Country Link
US (3) US11235023B2 (sr)
EP (2) EP3463280B1 (sr)
JP (4) JP2019523222A (sr)
KR (2) KR102511284B1 (sr)
CN (3) CN109310613A (sr)
AU (2) AU2017273507B2 (sr)
BR (2) BR112018074551B1 (sr)
CA (2) CA3024522A1 (sr)
CL (2) CL2018003390A1 (sr)
DK (2) DK3463280T3 (sr)
EA (2) EA201892819A1 (sr)
ES (2) ES2927948T3 (sr)
HR (2) HRP20221185T1 (sr)
HU (2) HUE060119T2 (sr)
IL (2) IL263112B2 (sr)
LT (2) LT3463281T (sr)
MA (2) MA45167A (sr)
MX (2) MX2018014752A (sr)
PH (2) PH12018502521A1 (sr)
PL (2) PL3463281T3 (sr)
PT (2) PT3463280T (sr)
RS (2) RS63639B1 (sr)
SG (3) SG10202113280XA (sr)
UA (2) UA125899C2 (sr)
WO (2) WO2017207117A1 (sr)
ZA (2) ZA201807773B (sr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3463281T (lt) * 2016-05-31 2022-09-26 Spexis Ag Beta-plaukų segtuko formos peptidomimetikai su elastazės inhibitoriniu aktyvumu ir aerozolinės jo dozavimo formos
KR20220133227A (ko) * 2020-01-30 2022-10-04 버텍스 파마슈티칼스 인코포레이티드 알파-1 항트립신 결핍증의 치료 방법
MX2023005982A (es) * 2020-11-23 2023-08-15 Spexis Ag Composiciones de un peptidomimetico de horquilla beta y formas de dosificacion en aerosol del mismo.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002509527A (ja) 1996-11-01 2002-03-26 ゾーマ コーポレイション 嚢胞性線維症におけるｂｐｉタンパク質産物の治療用途
EP1838290A2 (en) * 2005-01-21 2007-10-03 Alza Corporation Therapeutic peptide formulations for coating microneedles with improved stability containing at least one counterion
BRPI0520016B1 (pt) 2005-02-17 2021-11-16 Polyphor Ltd. Composto, composiqao farmaceutica, uso de composto e processo para a fabricaqao de composto
EP1712220A1 (en) * 2005-04-15 2006-10-18 PARI GmbH Spezialisten für effektive Inhalation Pharmaceutical aerosol composition
CA2641872A1 (en) 2006-02-09 2007-08-16 Kamada Ltd. Alpha-i antitrypsin for treating exacerbation episodes of pulmonary diseases
MX2008010222A (es) * 2006-02-10 2008-10-17 Pari Pharma Gmbh Antibioticos nebulizados para terapia de inhalacion.
WO2008025560A1 (en) * 2006-09-01 2008-03-06 Pari Pharma Gmbh Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
EP1927373B1 (en) * 2006-11-30 2012-08-22 PARI Pharma GmbH Inhalation nebulizer
PL2567691T3 (pl) 2011-09-12 2015-05-29 Meiji Seika Pharma Co Ltd Kompozycje wodne obejmujące arbekacynę
WO2015096672A1 (zh) 2013-12-23 2015-07-02 石家庄铁道大学 测试装置
WO2015098872A1 (ja) 2013-12-26 2015-07-02 株式会社カネカ 太陽電池のｉ‐ｖ測定方法、太陽電池のｉ‐ｖ測定装置、太陽電池の製造方法、太陽電池モジュールの製造方法、および太陽電池モジュール
HRP20221046T1 (hr) * 2013-12-27 2023-01-20 Spexis Ag Beta-ukosni peptidomimetici kao selektivni inhibitori elastaze
JP6499182B2 (ja) * 2013-12-27 2019-04-10 ポリフォー・アクチェンゲゼルシャフトＰｏｌｙｐｈｏｒ Ａｇ 選択的エラスターゼ阻害剤としてのβ−ヘアピンペプチド模倣体
LT3463281T (lt) * 2016-05-31 2022-09-26 Spexis Ag Beta-plaukų segtuko formos peptidomimetikai su elastazės inhibitoriniu aktyvumu ir aerozolinės jo dozavimo formos

Also Published As

Publication number Publication date
EP3463280B1 (en) 2022-07-06
JP7286319B2 (ja) 2023-06-05
AU2017273508A1 (en) 2018-12-13
EA201892819A1 (ru) 2019-05-31
US11844823B2 (en) 2023-12-19
PL3463280T3 (pl) 2022-11-07
CN109195580A (zh) 2019-01-11
CA3024522A1 (en) 2017-12-07
HUE060393T2 (hu) 2023-02-28
JP2019523222A (ja) 2019-08-22
JP2023017793A (ja) 2023-02-07
US20220023379A1 (en) 2022-01-27
HRP20221185T1 (hr) 2022-12-09
CA3024521A1 (en) 2017-12-07
KR102511284B1 (ko) 2023-03-16
PH12018502521A1 (en) 2019-10-21
LT3463280T (lt) 2022-09-26
CN116159024A (zh) 2023-05-26
KR20190011750A (ko) 2019-02-07
WO2017207118A1 (en) 2017-12-07
SG11201810138XA (en) 2018-12-28
US11235024B2 (en) 2022-02-01
US11235023B2 (en) 2022-02-01
KR102480800B1 (ko) 2022-12-22
IL263112B2 (en) 2023-10-01
US20200230203A1 (en) 2020-07-23
ES2927948T3 (es) 2022-11-14
DK3463281T3 (da) 2022-09-26
AU2017273507B2 (en) 2022-03-17
SG11201810137UA (en) 2018-12-28
KR20190015309A (ko) 2019-02-13
US20200230202A1 (en) 2020-07-23
WO2017207117A1 (en) 2017-12-07
ZA201807773B (en) 2022-07-27
IL263112B1 (en) 2023-06-01
BR112018074551B1 (pt) 2022-02-08
DK3463280T3 (da) 2022-09-26
AU2017273508B2 (en) 2022-07-28
PT3463280T (pt) 2022-10-07
ZA201807772B (en) 2022-10-26
PT3463281T (pt) 2022-10-07
HRP20221194T1 (hr) 2022-12-09
JP2019523763A (ja) 2019-08-29
IL263114B2 (en) 2023-12-01
BR112018074551A2 (pt) 2019-03-06
MX2018014425A (es) 2019-03-28
EP3463281A1 (en) 2019-04-10
IL263114B1 (en) 2023-08-01
IL263114A (en) 2018-12-31
PH12018502522A1 (en) 2019-10-21
MA45167A (fr) 2019-04-10
AU2017273507A1 (en) 2018-12-13
CL2018003391A1 (es) 2019-05-03
BR112018074532B1 (pt) 2022-02-08
UA125899C2 (uk) 2022-07-06
EP3463281B1 (en) 2022-07-06
UA125900C2 (uk) 2022-07-06
HUE060119T2 (hu) 2023-02-28
MX2018014752A (es) 2019-04-25
LT3463281T (lt) 2022-09-26
EP3463280A1 (en) 2019-04-10
CL2018003390A1 (es) 2019-05-03
EA039603B1 (ru) 2022-02-16
SG10202113280XA (en) 2021-12-30
MA45168A (fr) 2019-04-10
JP7286319B6 (ja) 2023-06-16
JP2022078013A (ja) 2022-05-24
CN109310613A (zh) 2019-02-05
PL3463281T3 (pl) 2022-11-07
IL263112A (en) 2018-12-31
CA3024521C (en) 2023-06-20
RS63639B1 (sr) 2022-10-31
EA201892818A1 (ru) 2019-05-31
BR112018074532A2 (pt) 2019-03-19
ES2928050T3 (es) 2022-11-15

Similar Documents

Publication Publication Date Title
IL257706A (en) Peptidomimetic macrocycles and their uses
EP3302442A4 (en) PHARMACEUTICAL FORM AND USE THEREOF
IL254444A0 (en) Peptidomimetic macrocycles and their uses
GB201516555D0 (en) Event detection and summarisation
EP3114217A4 (en) Caspase polypeptides having modified activity and uses thereof
EP3255059A4 (en) Antimicrobial peptide wy-21 and use thereof
ZA201702162B (en) Insecticidal polypeptides having improved activity spectrum and uses thereof
ZA201509326B (en) Insecticidal polypeptides having broad spectrum activity and uses thereof
EP3250122A4 (en) Finger ring electrocardiogram monitor trigger systems and associated methods
EP3274922A4 (en) Reliable fingertip and palm detection
EP3418292A4 (en) PEPTIDE WITH MELANINE GENERATION ACTIVITY AND USE THEREOF
ZA201807772B (en) Beta-hairpin peptidomimetic with elastase inhibitory activity and aerosol dosage forms thereof
EP3677590A4 (en) PEPTIDE WITH WRINKLE MITIGATION AND ASSOCIATED USES
EP3444263A4 (en) PEPTIDE HAVING ANTI-INFLAMMATORY ACTIVITY AND USE THEREOF
ZA201702168B (en) Insecticidal polypeptides having broad spectrum activity and uses thereof
EP3263584A4 (en) Peptide for targeting autophagic cells and use thereof
ZA201804864B (en) Insecticidal polypeptides having improved activity spectrum and uses thereof
EP3401326A4 (en) NOVEL PEPTIDE HAVING HYDROLYTIC ACTIVITY AND USE THEREOF
ZA202001823B (en) Compound having erk kinase inhibitory activity and use thereof
EP3500950A4 (en) MEASUREMENT AND ANALYSIS OF PHYSICAL ACTIVITY
IL283620A (en) Compounds with pde9a prophylactic activity, and their medicinal uses
IL283619A (en) Compounds with pde9a prophylactic activity, and their medicinal use
GB2568553B (en) Activity detection
GB201617761D0 (en) Medicament and assay
GB201617726D0 (en) Medicament and assay